Sort by
Refine Your Search
-
Listed
-
Category
-
Country
-
Program
-
Employer
-
Field
-
of their respective concentrations will be investigated and correlated with the velocity field recorded by PIV (Particle Image Velocimetry). In parallel with the use of standard post-processing methods, an innovative
-
21 Mar 2026 Job Information Organisation/Company CNRS Department Laboratoire des Signaux et Systèmes Research Field Engineering Computer science Mathematics Researcher Profile First Stage Researcher
-
10 Mar 2026 Job Information Organisation/Company CNRS Department Institut de Biologie Valrose Research Field Biological sciences Medical sciences Pharmacological sciences Researcher Profile
-
7 Feb 2026 Job Information Organisation/Company CNRS Department Institut de Recherche en Informatique de Toulouse Research Field Computer science Mathematics » Algorithms Researcher Profile First
-
for the turbomachinery design optimization process conducted by a parallel PhD student at LMFA. The numerical solver involved is ProLB. It is an innovative Computational Fluid Dynamics (CFD) software solution developed
-
6 Mar 2026 Job Information Organisation/Company Nantes Université Department CEISAM UMR-CNRS 6230 Research Field Chemistry Researcher Profile First Stage Researcher (R1) Positions PhD Positions
-
24 Jan 2026 Job Information Organisation/Company CNRS Department Laboratoire d'Informatique de Grenoble Research Field Computer science Researcher Profile First Stage Researcher (R1) Application
-
2030 program (see https://www.pepr-risques.fr/fr/programme-de-recherche-risques-irima ). IRIMA is led by CNRS, Grenoble Alpes University and BRGM, and aims to structure and strengthen hazard and risk
-
24 Jan 2026 Job Information Organisation/Company CNRS Department Laboratoire Jacques-Louis Lions Research Field Mathematics History » History of science Researcher Profile Recognised Researcher (R2
-
at the earliest on 1st August, 2026. The position is funded by the Marie Skłodowska-Curie Doctoral Network (MSCA-DN), on “Understanding Lipid ImmunoMetabolism to treat disease” (UNLIMITED) within the Horizon Europe